This paper is only available as a PDF. To read, Please Download here.
Somatosensory stimuli such as touch, temperature and pain are transduced in the periphery
and transmitted to the central nervous system by primary sensory neurons, which cell
bodies reside in sensory ganglia such as dorsal root ganglia (DRGs). Although DRG
are complex tissues with neuronal and non-neuronal cells, diversity of non-neuronal
cells and their function in homeostasis and pain are still unclear. Satellite glial
cells (SGCs) are among the most abundant non-neuronal cells in DRGs and tightly envelop
neurons providing metabolic and trophic support, buffering extracellular ions and
neurotransmitters, and enabling neuromodulation. Importantly, it is now clear that
SGCs can control neuroinflammation and neuronal excitability contributing to development
of pathological pain. Yet our understanding of SGC biology and molecular signaling
is still rudimentary. Here, we used single-cell RNA sequencing (scRNA-seq) to study
the heterogeneity of non-neuronal cell populations in DRGs and, in particular, to
understand SGC biology and molecular signaling in the context of modulation of somatosensory
stimuli and pathological pain. We identified a distinct gene expression for non-neuronal
cells and heterogeneity of SGCs. In particular, we found an enriched expression of
the tissue inhibitor metalloproteinase 3 (TIMP3) and other metalloproteinases in SGCs,
and demonstrated using small interfering RNA and neutralizing antibody that TIMP3
controls somatosensory stimuli. TIMP3 expression is decrease after paclitaxel, and
its rescue by delivery of a recombinant TIMP3 protein reversed and prevented paclitaxel-induced
pain. We also established that paclitaxel directly modulates metalloproteinase signaling
in cultured SGCs, which can be used to screen novel drugs for pain. Thus, our findings
reveal a metalloproteinase signaling in SGCs for the proper processing of somatosensory
stimuli and discovery of new treatment of pain. Grant support from NS113243.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Journal of PainAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2022 Published by Elsevier Inc.